BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26613251)

  • 1. Resveratrol Regulates Activated Hepatic Stellate Cells by Modulating NF-κB and the PI3K/Akt Signaling Pathway.
    Zhang DQ; Sun P; Jin Q; Li X; Zhang Y; Zhang YJ; Wu YL; Nan JX; Lian LH
    J Food Sci; 2016 Jan; 81(1):H240-5. PubMed ID: 26613251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomeric proanthocyanidin derived from grape seeds inhibited NF-κB signaling in activated HSC: Involvement of JNK/ERK MAPK and PI3K/Akt pathways.
    Jiang M; Wu YL; Li X; Zhang Y; Xia KL; Cui BW; Lian LH; Nan JX
    Biomed Pharmacother; 2017 Sep; 93():674-680. PubMed ID: 28692939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells.
    Bai T; Lian LH; Wu YL; Wan Y; Nan JX
    Int Immunopharmacol; 2013 Feb; 15(2):275-81. PubMed ID: 23318601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway.
    Hu N; Wang C; Dai X; Zhou M; Gong L; Yu L; Peng C; Li Y
    J Ethnopharmacol; 2020 Feb; 248():112361. PubMed ID: 31683033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-fibrotic effect of thymoquinone on hepatic stellate cells.
    Ghazwani M; Zhang Y; Gao X; Fan J; Li J; Li S
    Phytomedicine; 2014 Feb; 21(3):254-60. PubMed ID: 24182989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
    Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumol induces HSC-T6 cell death through suppression of Bcl-2: involvement of PI3K and NF-κB pathways.
    Chen G; Wang Y; Li M; Xu T; Wang X; Hong B; Niu Y
    Eur J Pharm Sci; 2014 Dec; 65():21-8. PubMed ID: 25220584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and Akt.
    Kim JK; Han NR; Park SM; Jegal KH; Jung JY; Jung EH; Kim EO; Kim D; Jung DH; Lee JR; Park CA; Ku SK; Cho IJ; Kim SC
    Food Chem Toxicol; 2020 Jan; 135():111044. PubMed ID: 31830547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling.
    Li X; Jin Q; Wu YL; Sun P; Jiang S; Zhang Y; Zhang DQ; Zhang YJ; Lian LH; Nan JX
    Int Immunopharmacol; 2016 Jul; 36():263-270. PubMed ID: 27179306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis.
    Kim BH; Yoon JH; Yang JI; Myung SJ; Lee JH; Jung EU; Yu SJ; Kim YJ; Lee HS; Kim CY
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1859-68. PubMed ID: 23808824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
    Chen Y; Zeng Z; Shen X; Wu Z; Dong Y; Cheng JC
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation through TLR4/NF-kB pathway.
    Wang PP; Xie DY; Liang XJ; Peng L; Zhang GL; Ye YN; Xie C; Gao ZL
    PLoS One; 2012; 7(8):e43408. PubMed ID: 22927965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway.
    Liu M; Xu Y; Han X; Yin L; Xu L; Qi Y; Zhao Y; Liu K; Peng J
    Sci Rep; 2015 Dec; 5():18038. PubMed ID: 26655640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
    Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
    J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
    Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
    J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of κB kinase α/inhibitor of κB-α/nuclear factor-κB pathway.
    Ping J; Gao AM; Qin HQ; Wei XN; Bai J; Liu L; Li XH; Li RW; Ao Y; Wang H
    J Pharmacol Exp Ther; 2011 Nov; 339(2):694-703. PubMed ID: 21862660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.
    Guo J; Loke J; Zheng F; Hong F; Yea S; Fukata M; Tarocchi M; Abar OT; Huang H; Sninsky JJ; Friedman SL
    Hepatology; 2009 Mar; 49(3):960-8. PubMed ID: 19085953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
    Shirai Y; Yoshiji H; Noguchi R; Kaji K; Aihara Y; Douhara A; Moriya K; Namisaki T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2013 Apr; 28(4):723-30. PubMed ID: 23301938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.